# Eventide Gilead N (ETGLX)

> Source: Nexqual · https://nexqual.com/ETGLX · data as of 2026-10-24 00:01 UTC · cite as "Nexqual, Eventide Gilead N (ETGLX), nexqual.com/ETGLX" · informational, not investment advice.

**Price:** USD 58.25 (-0.12% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 58.25 · day 58.25–58.25 · 52w 48.82–67.01 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +10.9% vs S&P 500 +13.4%; 5Y +2.3% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +10.9% | +2.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +10.9% | +0.5% |
| Volatility (annualized) | 20.9% | 23.1% |
| Max drawdown | -14.4% (Jan 2026→Mar 2026) | -40.8% (Nov 2021→Oct 2022) |

## Peers
ETNHX (Eventide Healthcare & Life Scie) USD 49.43 -0.00% · ETILX (Eventide Gilead Fund Institutio) USD 60.84 -0.00% · GTLLX (Glenmede Large Cap Growth Ptf) USD 33.97 -0.00% · BUFOX (Buffalo Early Stage Growth Fund) USD 16.73 +0.00% · PARWX (Parnassus Endeavor Fund - Inves) USD 64.4 -0.00%

## More
Full page: https://nexqual.com/ETGLX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt